BOSTON, March 12, 2012 /PRNewswire/ -- Block & Leviton LLP, a Boston based law firm with experience representing investors nationwide, is investigating possible breaches of fiduciary duties by the Board of Directors of Zoll Medical Corp. ("Zoll" or the "Company") (Nasdaq: ZOLL) concerning an offer by Asahi Kasei Corp. to acquire the company for approximately $2.2 billion.
The investigation centers on whether Zoll's Board of Directors adequately protected shareholder interests, and properly maximized shareholder value, by agreeing to sell the Company for $93 per share, which represents a mere 24% premium over Friday's closing price. Some stock market analysts have targeted Zoll's price as high as $100 per share and analysts at another firm believe Zoll may receive higher offers.
If you own stock in Zoll and have any questions, or are interested in learning more about how to protect your rights, please contact us.
BLOCK & LEVITON LLP
Scott Mays, Esq.
Jeffrey Block, Esq.
The attorneys at Block & Leviton have more than 50 years of experience in representing individual and institutional investors in shareholder rights actions.
This may constitute attorney advertising.
SOURCE Block & Leviton LLP